Macquarie Group’s Tenet Healthcare THC Stock Holding History

Macquarie Group’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$61K	Buy	326 +2	+0.6%	+$368	﹤0.01%	827
2026 Q1	$61.1K	Buy	+324	New	+$68.3K	﹤0.01%	788
2025 Q4	–	Sell	-10,300	Closed	-$2.09M	–	1444
2025 Q3	$2.09M	Hold	10,300	–	–	﹤0.01%	1158
2025 Q2	$1.81M	Sell	10,300 -6,823	-40%	-$1.03M	﹤0.01%	1251
2025 Q1	$2.3M	Buy	+17,123	New	+$2.25M	﹤0.01%	1175
2024 Q4	–	Sell	-2,284	Closed	-$380K	–	1724
2024 Q3	$380K	Buy	+2,284	New	+$345K	﹤0.01%	1505
2022 Q4	–	Sell	-1,390	Closed	-$122K	–	2103
2022 Q3	$122K	Sell	1,390 -982	-41%	-$58.3K	﹤0.01%	1715
2022 Q2	$125K	Sell	2,372 -102,377	-98%	-$7.12M	﹤0.01%	1813
2022 Q1	$9M	Buy	104,749 +102,774	+5,204%	+$8.44M	0.01%	955
2021 Q4	$161K	Hold	1,975	–	–	﹤0.01%	1809
2021 Q3	$131K	Hold	1,975	–	–	﹤0.01%	1897
2021 Q2	$132K	Sell	1,975 -1,589	-45%	-$98.5K	﹤0.01%	1895
2021 Q1	$185K	Sell	3,564 -1,030	-22%	-$52.1K	﹤0.01%	1725
2020 Q4	$183K	Hold	4,594	–	–	﹤0.01%	1692
2020 Q3	$113K	Hold	4,594	–	–	﹤0.01%	1748
2020 Q2	$83K	Buy	4,594 +794	+21%	+$15.6K	﹤0.01%	1807
2020 Q1	$55K	Hold	3,800	–	–	﹤0.01%	1794
2019 Q4	$145K	Hold	3,800	–	–	﹤0.01%	1697
2019 Q3	$84K	Sell	3,800 -9,600	-72%	-$205K	﹤0.01%	1762
2019 Q2	$277K	Buy	+13,400	New	+$309K	﹤0.01%	1502
2019 Q1	–	Sell	-1,800	Closed	-$31K	–	2016
2018 Q4	$31K	Sell	1,800 -1,000	-36%	-$24.2K	﹤0.01%	1691
2018 Q3	$80K	Sell	2,800 -195,333	-99%	-$6.45M	﹤0.01%	1633
2018 Q2	$6.65M	Sell	198,133 -33,479	-14%	-$1.04M	0.01%	716
2018 Q1	$5.62M	Buy	+231,612	New	+$4.61M	0.01%	723
2016 Q4	–	Sell	-100,000	Closed	-$2.27M	–	1581
2016 Q3	$2.27M	Sell	100,000 -60,000	-38%	-$1.56M	﹤0.01%	923
2016 Q2	$4.42M	Hold	160,000	–	–	0.01%	739
2016 Q1	$4.63M	Sell	160,000 -15,000	-9%	-$390K	0.01%	723
2015 Q4	$5.3M	Buy	175,000 +15,000	+9%	+$492K	0.01%	688
2015 Q3	$5.91M	Hold	160,000	–	–	0.01%	676
2015 Q2	$9.26M	Hold	160,000	–	–	0.02%	570
2015 Q1	$7.92M	Buy	160,000 +15,000	+10%	+$701K	0.02%	608
2014 Q4	$7.35M	Buy	145,000 +25,000	+21%	+$1.31M	0.02%	604
2014 Q3	$7.13M	Sell	120,000 -10,000	-8%	-$558K	0.02%	595
2014 Q2	$6.1M	Sell	130,000 -25,000	-16%	-$1.13M	0.01%	649
2014 Q1	$6.64M	Hold	155,000	–	–	0.01%	601
2013 Q4	$6.53M	Buy	155,000 +50,000	+48%	+$2.18M	0.01%	572
2013 Q3	$4.33M	Buy	105,000 +65,000	+163%	+$2.72M	0.01%	653
2013 Q2	$1.84M	Buy	+40,000	New	+$1.79M	﹤0.01%	941

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Macquarie Group's THC Position: Q2 2026 in Review

Macquarie Group increased its Tenet Healthcare (THC) stake by 0.62% in Q2 2026, buying an estimated $368 and bringing the position to 326 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #827.

Macquarie Group first reported a position in THC in Q2 2013 and has held it in 38 quarters since. The position peaked at $9.26M in Q2 2015. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Macquarie Group held 326 shares of Tenet Healthcare worth $61K as of Q2 2026.
Macquarie Group bought 2 Tenet Healthcare shares in Q2 2026, an estimated $368.
Tenet Healthcare made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #827 holding.
Macquarie Group first reported a position in Tenet Healthcare in Q2 2013 and has held it in 38 quarters since.
Macquarie Group's Tenet Healthcare position peaked at $9.26M in Q2 2015.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.